Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis

NCT01554124 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Meningitis

Interventions

DRUG: Meropenem

Sponsor

PENTA Foundation

Collaborators

[object Object]